The promise of quicker recovery, reduced trauma and improved clinical outcomes has been the catalyst behind the development of surgical robotics, with the global market for robot-assisted surgery forecast to be worth £31bn by 2026.
Medical companies around the world are racing to develop technologies that make surgeries safer and less invasive. Just yesterday US-business Johnson & Johnson agreed to buy surgical robotics company Auris Health Inc for £2.65bn. Auris’ Monarch Platform reportedly improves upon existing minimally invasive techniques by integrating robotics, micro-instrumentation, endoscope design, sensing, and data science into one…
This content is for subscribers only. Subscribe now for free to read the full article.
Already a subscriber? Login